Sotera Health Company

NasdaqGS:SHC 주식 보고서

시가총액: US$3.3b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Sotera Health 관리

관리 기준 확인 3/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Michael Petras

최고 경영자

US$9.7m

총 보상

CEO 급여 비율10.8%
CEO 임기8yrs
CEO 소유권2.0%
경영진 평균 재임 기간3.7yrs
이사회 평균 재임 기간3.7yrs

최근 관리 업데이트

Recent updates

Sotera Health (NASDAQ:SHC) Takes On Some Risk With Its Use Of Debt

Jun 25
Sotera Health (NASDAQ:SHC) Takes On Some Risk With Its Use Of Debt

Sotera Health Company (NASDAQ:SHC) Shares Could Be 42% Below Their Intrinsic Value Estimate

May 30
Sotera Health Company (NASDAQ:SHC) Shares Could Be 42% Below Their Intrinsic Value Estimate

The Price Is Right For Sotera Health Company (NASDAQ:SHC) Even After Diving 29%

Mar 21
The Price Is Right For Sotera Health Company (NASDAQ:SHC) Even After Diving 29%

Sotera Health Company Just Missed Earnings - But Analysts Have Updated Their Models

Mar 01
Sotera Health Company Just Missed Earnings - But Analysts Have Updated Their Models

McIntyre Partnerships - Sotera Health Company: A Notable Outlier At A Discount

Feb 08

Is Sotera Health (NASDAQ:SHC) A Risky Investment?

Feb 06
Is Sotera Health (NASDAQ:SHC) A Risky Investment?

Investors Still Aren't Entirely Convinced By Sotera Health Company's (NASDAQ:SHC) Revenues Despite 26% Price Jump

Dec 28
Investors Still Aren't Entirely Convinced By Sotera Health Company's (NASDAQ:SHC) Revenues Despite 26% Price Jump

Sotera Health Company's (NASDAQ:SHC) Intrinsic Value Is Potentially 33% Above Its Share Price

Dec 11
Sotera Health Company's (NASDAQ:SHC) Intrinsic Value Is Potentially 33% Above Its Share Price

An Intrinsic Calculation For Sotera Health Company (NASDAQ:SHC) Suggests It's 37% Undervalued

Sep 10
An Intrinsic Calculation For Sotera Health Company (NASDAQ:SHC) Suggests It's 37% Undervalued

Sotera Health Company (NASDAQ:SHC) Shares Could Be 24% Below Their Intrinsic Value Estimate

Jun 05
Sotera Health Company (NASDAQ:SHC) Shares Could Be 24% Below Their Intrinsic Value Estimate

Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 34%?

Feb 13
Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 34%?

Market Participants Recognise Sotera Health Company's (NASDAQ:SHC) Earnings Pushing Shares 29% Higher

Nov 24
Market Participants Recognise Sotera Health Company's (NASDAQ:SHC) Earnings Pushing Shares 29% Higher

Sotera Health plunges 20% after jury awards $363M against its Sterigenics unit

Sep 19

Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 49%?

Sep 08
Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 49%?

Sotera Health GAAP EPS of $0.11 misses by $0.05, revenue of $266.64M beats by $10.34M

Aug 04

Is Sotera Health Company (NASDAQ:SHC) Trading At A 46% Discount?

May 09
Is Sotera Health Company (NASDAQ:SHC) Trading At A 46% Discount?

Returns On Capital Are Showing Encouraging Signs At Sotera Health (NASDAQ:SHC)

Mar 16
Returns On Capital Are Showing Encouraging Signs At Sotera Health (NASDAQ:SHC)

Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 38%?

Jan 19
Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 38%?

CEO 보상 분석

Michael Petras 의 보수는 Sotera Health 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

US$55m

Dec 31 2023US$10mUS$1m

US$51m

Sep 30 2023n/an/a

-US$306m

Jun 30 2023n/an/a

-US$268m

Mar 31 2023n/an/a

-US$261m

Dec 31 2022US$17mUS$1m

-US$234m

Sep 30 2022n/an/a

US$121m

Jun 30 2022n/an/a

US$123m

Mar 31 2022n/an/a

US$135m

Dec 31 2021US$2mUS$1m

US$115m

Sep 30 2021n/an/a

US$36m

Jun 30 2021n/an/a

US$9m

Mar 31 2021n/an/a

-US$26m

Dec 31 2020US$17mUS$728k

-US$39m

Sep 30 2020n/an/a

-US$23m

Jun 30 2020n/an/a

-US$28m

Mar 31 2020n/an/a

-US$29m

Dec 31 2019US$2mUS$700k

-US$21m

보상 대 시장: Michael 의 총 보상 ($USD 9.70M )은 US 시장( $USD 6.80M ).

보상과 수익: Michael 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.


CEO

Michael Petras (55 yo)

8yrs

테뉴어

US$9,701,005

보상

Mr. Michael B. Petras Jr., serves as Chief Executive Officer at Sotera Health Company since June 20, 2016. He has been Chairman of the Board at Sotera Health Company since October 2020. He also served as t...


리더십 팀

이름위치테뉴어보상소유권
Michael Petras
Chairman & CEO8yrsUS$9.70m1.98%
$ 66.4m
Jonathan Lyons
Senior VP & CFOless than a yearUS$2.18m데이터 없음
Alexander Dimitrief
Senior VP1.6yrsUS$862.18k0.083%
$ 2.8m
Michael Rutz
President of Sterigenics3.7yrsUS$2.03m0.17%
$ 5.6m
Robert Hauzie
Chief Information Officer5.4yrs데이터 없음데이터 없음
Kristin Gibbs
Chief Marketing Officer7.6yrs데이터 없음데이터 없음
William Lehmann
Senior Vice President of Strategy & Corporate Development2.4yrs데이터 없음데이터 없음
Sally Turner
Chief Human Resources Officer5.4yrs데이터 없음데이터 없음
Kathleen Hoffman
Senior Vice President of Global Environmentalno data데이터 없음데이터 없음
Joseph Shrawder
President of Nelson Labs3.7yrs데이터 없음데이터 없음
Riaz Bandali
President of Nordion2.3yrs데이터 없음데이터 없음
Jason Peterson
VP & Treasurerno data데이터 없음데이터 없음

3.7yrs

평균 재임 기간

54.5yo

평균 연령

경험이 풍부한 관리: SHC 의 관리팀은 경험 ( 3.7 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Michael Petras
Chairman & CEO8yrsUS$9.70m1.98%
$ 66.4m
David Donnini
Independent Director3.7yrsUS$302.50k0.015%
$ 491.6k
James Neary
Independent Director3.7yrsUS$320.00k0.015%
$ 491.6k
Constantine Mihas
Independent Director3.7yrsUS$305.00k0.015%
$ 491.6k
Sean Cunningham
Independent Director3.7yrsUS$302.50k0.015%
$ 491.6k
Vincent Petrella
Independent Director3.6yrsUS$325.00k0.015%
$ 491.6k
Ann Klee
Independent Director3.7yrsUS$322.50k0.031%
$ 1.0m
Robert Knauss
Independent Director1.7yrsUS$300.00k0.0056%
$ 185.9k
Ruoxi Chen
Independent Director3.6yrsUS$302.50k0.015%
$ 491.6k
David Wheadon
Independent Director3.1yrsUS$310.00k0.013%
$ 422.3k
Karen Flynn
Independent Directorless than a yearUS$9.99k데이터 없음

3.7yrs

평균 재임 기간

61yo

평균 연령

경험이 풍부한 이사회: SHC 의 이사회경험(평균 재직 기간 3.7 년)으로 간주됩니다.